Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8239139 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
Thalidomide provided no survival benefit for patients with multiple, large, or midbrain metastases when combined with WBRT; nearly half the patients discontinued thalidomide due to side effects.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jonathan P.S. M.D., F.R.C.P.C., Brian M.S., Arnab M.D., Al W.K. M.D., Walter J. M.D., H. Ian M.D., Ph.D., Benjamin M.D., David G. M.D., Randall H. M.D., M.B.A., Minesh P. M.D.,